173 related articles for article (PubMed ID: 3030862)
1. Safety and efficacy of a combined parapox/BVD vaccine.
Büttner M
Dev Biol Stand; 1986; 65():221-6. PubMed ID: 3030862
[TBL] [Abstract][Full Text] [Related]
2. Response of cattle persistently infected with noncytopathic bovine viral diarrhea virus to vaccination for bovine viral diarrhea and to subsequent challenge exposure with cytopathic bovine viral diarrhea virus.
Bolin SR; McClurkin AW; Cutlip RC; Coria MF
Am J Vet Res; 1985 Dec; 46(12):2467-70. PubMed ID: 3002214
[TBL] [Abstract][Full Text] [Related]
3. Specificity of neutralizing and precipitating antibodies induced in healthy calves by monovalent modified-live bovine viral diarrhea virus vaccines.
Bolin SR; Ridpath JF
Am J Vet Res; 1989 Jun; 50(6):817-21. PubMed ID: 2548419
[TBL] [Abstract][Full Text] [Related]
4. Viral and viral protein specificity of antibodies induced in cows persistently infected with noncytopathic bovine viral diarrhea virus after vaccination with cytopathic bovine viral diarrhea virus.
Bolin SR
Am J Vet Res; 1988 Jul; 49(7):1040-4. PubMed ID: 2844105
[TBL] [Abstract][Full Text] [Related]
5. Serologic detection and practical consequences of antigenic diversity among bovine viral diarrhea viruses in a vaccinated herd.
Bolin SR; Littledike ET; Ridpath JF
Am J Vet Res; 1991 Jul; 52(7):1033-7. PubMed ID: 1654030
[TBL] [Abstract][Full Text] [Related]
6. Clinical evaluation of a temperature-sensitive bovine viral diarrhea vaccine strain.
Lobmann M; Charlier P; Florent G; Zygraich N
Am J Vet Res; 1984 Dec; 45(12):2498-503. PubMed ID: 6098205
[TBL] [Abstract][Full Text] [Related]
7. Safety of a temperature-sensitive vaccine strain of bovine viral diarrhea virus in pregnant cows.
Lobmann M; Charlier P; Klaassen CL; Zygraich N
Am J Vet Res; 1986 Mar; 47(3):557-60. PubMed ID: 3008601
[TBL] [Abstract][Full Text] [Related]
8. [Vaccination of calves with contaminated batches of bovine herpes virus 1 vaccines did not result in infection with bovine virus diarrhea virus].
Antonis AF; van Oirschot JT; van Es M; Bruschke CJ
Tijdschr Diergeneeskd; 2001 Mar; 126(6):208-11. PubMed ID: 11285641
[TBL] [Abstract][Full Text] [Related]
9. Range of viral neutralizing activity and molecular specificity of antibodies induced in cattle by inactivated bovine viral diarrhea virus vaccines.
Bolin SR; Ridpath JF
Am J Vet Res; 1990 May; 51(5):703-7. PubMed ID: 2159737
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of a modified live virus type-1a bovine viral diarrhea virus vaccine (Singer strain) against a type-2 (strain 890) challenge.
Fairbanks K; Schnackel J; Chase CC
Vet Ther; 2003; 4(1):24-34. PubMed ID: 12756633
[TBL] [Abstract][Full Text] [Related]
11. Compatibility of a live infectious bovine rhinotraheitis (IBR) marker vaccine and an inactivated bovine viral diarrhoea virus (BVDV) vaccine.
Alvarez M; Bielsa JM; Santos L; Makoschey B
Vaccine; 2007 Sep; 25(36):6613-7. PubMed ID: 17669560
[TBL] [Abstract][Full Text] [Related]
12. Maternal immunity to infectious bovine rhinotracheitis and bovine viral diarrhea viruses: duration and effect on vaccination in young calves.
Brar JS; Johnson DW; Muscoplat CC; Shope RE; Meiske JC
Am J Vet Res; 1978 Feb; 39(2):241-4. PubMed ID: 204233
[TBL] [Abstract][Full Text] [Related]
13. [BVD approach: vaccination and eradication].
Verberne LR
Tijdschr Diergeneeskd; 2000 Apr; 125(7):218-21. PubMed ID: 10775986
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of multiple immune parameters after vaccination with modified live or killed bovine viral diarrhea virus vaccines.
Reber AJ; Tanner M; Okinaga T; Woolums AR; Williams S; Ensley DT; Hurley DJ
Comp Immunol Microbiol Infect Dis; 2006 Jan; 29(1):61-77. PubMed ID: 16543046
[TBL] [Abstract][Full Text] [Related]
15. Specificity and duration of neutralizing antibodies induced in healthy cattle after administration of a modified-live virus vaccine against bovine viral diarrhea.
Cortese VS; Whittaker R; Ellis J; Ridpath JF; Bolin SR
Am J Vet Res; 1998 Jul; 59(7):848-50. PubMed ID: 9659549
[TBL] [Abstract][Full Text] [Related]
16. Studies on transplacental transmissibility of a bovine virus diarrhoea (BVD) vaccine virus in cattle. II. Inoculation of pregnant cows without detectable neutralizing antibodies to BVD virus 90-229 days before parturition (51st to 190th day of gestation).
Liess B; Orban S; Frey HR; Trautwein G; Wiefel W; Blindow H
Zentralbl Veterinarmed B; 1984 Oct; 31(9):669-81. PubMed ID: 6097070
[No Abstract] [Full Text] [Related]
17. Mucosal immune response in newborn Holstein calves that had maternally derived antibodies and were vaccinated with an intranasal multivalent modified-live virus vaccine.
Hill KL; Hunsaker BD; Townsend HG; van Drunen Littel-van den Hurk S; Griebel PJ
J Am Vet Med Assoc; 2012 May; 240(10):1231-40. PubMed ID: 22559114
[TBL] [Abstract][Full Text] [Related]
18. Safety of a mutagen-attenuated Rift Valley fever virus vaccine in fetal and neonatal bovids.
Morrill JC; Mebus CA; Peters CJ
Am J Vet Res; 1997 Oct; 58(10):1110-4. PubMed ID: 9328663
[TBL] [Abstract][Full Text] [Related]
19. Immunization against mucosal disease--bovine viral Diarrhea (MD-BVD) in calves applying lapinized vaccine against swine fever and a modified live virus of MD-BVD.
Haralambiev H; Tsvetkov P; Nikolov A; Gaytandgieva R
Arch Exp Veterinarmed; 1975; 29(5):701-4. PubMed ID: 180923
[TBL] [Abstract][Full Text] [Related]
20. [BVD (bovine virus diarrhea) and IBR (infectious bovine rhinotracheitis): serologic studies on 35 farms].
Franken P; Sol J; Wentink GH
Tijdschr Diergeneeskd; 1986 Dec; 111(23):1205-7. PubMed ID: 3027917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
